IndieBio:Building Biotech Startups [Harvard GSAS Biotech Club]


Monday, April 8, 2019, 12:00pm to 1:00pm


Harvard Medical School, Vanderbilt Hall, Vanderbilt Lounge, 107 Avenue Louis Pasteur, Boston, MA, 02115

"Biology has long been confined to the labs of academia and pharmaceutical giants. However we're undergoing an unprecedented shift as biology as a technology is enabling scientist-entrepreneurs to solve global challenges across industries. 
At IndieBio, we've funded 105 biotech startups in the last four years, most founded by grad students translating their academic discoveries into solutions in human and planetary health. Today we'll talk about what has changed to kickstart the biotech startup ecosystem, how IndieBio operates, examples of areas and companies funded, and lessons learned from  these startups."

Arvind Gupta IndieBio Founder SOSV Partner
Alex Kopelyan Program Director Partner
Also joining us to talk about their experience: 
-David Salzman, CEO of sRNAlytics & IB alum
-Hyunjun Park, CEO of Catalog & IB alum)

"IndieBio ( is the world’s leading biotechnology accelerator, located in downtown San Francisco. Companies from all over the world apply to be part of a 4 month acceleration program which includes $250,000 funding, dedicated mentorship, and 24/7 access to a co-working space and bio-safety level 1 & 2 labs. During the program, teams are focused on turning science into product, closing customers, raising investment, and developing leadership skills."